Home Stocks Dr. Lal PathLabs Ltd

Dr. Lal PathLabs Ltd

The live share price of Dr. Lal PathLabs Ltd (LALPATHLAB) as on 28 Sep 10:13am is ₹2,408.6 from NSE/BSE.

LALPATHLAB NSE

₹2,408.6 ▼-1.59% (-38.9)

As on Sep 28, 2023 03:43 PM IST

How do you feel today about Dr. Lal PathLabs Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

76.25

PB Ratio

11.84

Dividend Yield

0.25%

Sector PB

4.64

Sector PE

39.51

Sector Div Yld

0.79%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Health Care Providers & Services

Market Cap

Smallcap, ₹20,115 Cr

Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.

The following charts display the financial performance of the Dr. Lal PathLabs Ltd (LALPATHLAB) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Dr. Lal PathLabs Ltd (LALPATHLAB), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Health Care Providers & Services

Market Cap

Smallcap, ₹20,115 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	2,058 Cr	-3.8%
Operating Expense	407 Cr	+6.17%
Net Income	238 Cr	-30.74%
Net Profit Margin	11.6%	-28%
Earning Per Share	28	-30.76%
EBITDA	531 Cr	-13.33%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	815 Cr	+19.37%
Total Assets	2,382 Cr	+1.7%
Total Liabilities	683 Cr	-15.2%
Total Equity	1,699 Cr	+10.56%
Shares Outstanding	8.34 Cr	+0.07%
Price to Book	8.97	-36.31%
Return on Assets	10.11%	-41.32%
Return on Capital	22.44 Cr	-31.71%

Cash Flows

(INR)		Y/Y Change
Net Income	238 Cr	-30.74%
Cash from Operations	456 Cr	+2.09%
Cash from Investing	-287 Cr	-36.05%
Cash from Financing	-283 Cr	-307.53%
Net Change in Cash	-114 Cr	-185.49%
Free Cash Flow	411 Cr	-1497.15%

Shareholding Pattern

Total Promoter Holding

55.01%

Unpledged

Foreign Institutions

23.27%

Foreign Institutions

Retail & Others

13.09%

Retail & Others

Other Parties

Other Domestic Institutions

3.71%

Insurance Firms

Others

Mutual Funds

4.92%

Mutual Funds

Peers

APOLLOHOSP

Apollo Hospitals Enterprise Ltd

PE Ratio

108.69

1Y Return

▲17.6%

MAXHEALTH

Max Healthcare Institute Ltd

PE Ratio

46.97

1Y Return

▲38.67%

FORTIS

Fortis Healthcare Ltd

PE Ratio

43.82

1Y Return

▲31.85%

NH

Narayana Hrudayalaya Ltd

PE Ratio

31.9

1Y Return

▲52.55%

Latest News

Trade setup for Friday: Top 15 things to know before the opening bell

2 weeks ago on Moneycontrol

Change since news ▼-4.21%

A long build-up was seen in 71 stocks, including BHEL, Dr Lal PathLabs, Balrampur Chini Mills, Granules India, and ONGC. An increase in open interest (OI) and price indicates a build-up of long positions.

Technical Analysis: DLF, Zomato and Dr. Lal PathLabs

1 month ago on The Hindu Businessline

Change since news ▼-9.26%

DLF: Bullish Momentum, Potential for Rally to ₹550-560 by Year-End, with Strong Support at ₹440-430 Zone. Consider ₹445 Accumulation, Manage Risk with Stop-Loss at ₹405, Exit Target at ₹710 or Beyond. Zomato: Zomato Share Price Sees Bullish Reversal, Eyes Potential Rally to ₹115 and Beyond. Consider…

“Dr Lal PathLabs Ltd’s Share Price Rises 0.68% After 43.6% Increase in Profit for Q2 2023”

2 months ago on The Hindu Businessline

Change since news ▼-4.81%

Dr Lal PathLabs Ltd’s share price rose 0.68% after it reported 43.6% increase in profit for Q1 FY24. Revenues were up 7.76% to ₹541 crore. EBITDA rose 24.4% YoY to ₹146 crore. Intense competition in Delhi NCR may limit earnings growth. Stock downgraded to sell with revised target price of ₹2,110.

FAQs on Dr. Lal PathLabs Ltd

How to buy Dr. Lal PathLabs Ltd stocks?

You can easily buy the stocks/shares of Dr. Lal PathLabs Ltd (LALPATHLAB) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Dr. Lal PathLabs Ltd?

The stock price of Dr. Lal PathLabs Ltd as on 28 Sep 2023 is ₹2,408.6

What is the 52-week High and Low of Dr. Lal PathLabs Ltd?

The 52-week high and low of Dr. Lal PathLabs Ltd (LALPATHLAB) is ₹2,750 and ₹1,762.05.

What is the PE and PB ratio of Dr. Lal PathLabs Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Dr. Lal PathLabs Ltd are 76.25 and 11.84 respectively.

What are the peers or stocks similar to Dr. Lal PathLabs Ltd?

The peers or stocks similar to Dr. Lal PathLabs Ltd are Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd, Fortis Healthcare Ltd, Narayana Hrudayalaya Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Dr. Lal PathLabs Ltd belong to?

Dr. Lal PathLabs Ltd (LALPATHLAB) belongs to the Hospitals & Diagnostic Centres sector.

What is the Market Cap of Dr. Lal PathLabs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr. Lal PathLabs Ltd (LALPATHLAB) is ₹20,115 Cr as of 28 Sep 2023

Can't decide whether or not to buy Dr. Lal PathLabs Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.